103 related articles for article (PubMed ID: 21649466)
1. Clinical implications for girdin protein expression in breast cancer.
Ling Y; Jiang P; Cui SP; Ren YL; Zhu SN; Yang JP; Du J; Zhang Y; Liu JY; Zhang B
Cancer Invest; 2011 Jul; 29(6):405-10. PubMed ID: 21649466
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Girdin in the nucleus indicates worse prognosis for patients with estrogen receptor-positive breast cancer.
Peng WT; Hu X; Yao L; Jiang YZ; Shao ZM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S648-56. PubMed ID: 24793340
[TBL] [Abstract][Full Text] [Related]
3. Girdin protein: a new potential distant metastasis predictor of breast cancer.
Liu C; Zhang Y; Xu H; Zhang R; Li H; Lu P; Jin F
Med Oncol; 2012 Sep; 29(3):1554-60. PubMed ID: 22116776
[TBL] [Abstract][Full Text] [Related]
4. An actin-binding protein Girdin regulates the motility of breast cancer cells.
Jiang P; Enomoto A; Jijiwa M; Kato T; Hasegawa T; Ishida M; Sato T; Asai N; Murakumo Y; Takahashi M
Cancer Res; 2008 Mar; 68(5):1310-8. PubMed ID: 18316593
[TBL] [Abstract][Full Text] [Related]
5. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.
Crosier M; Scott D; Wilson RG; Griffiths CD; May FE; Westley BR
Clin Cancer Res; 1999 Oct; 5(10):2682-8. PubMed ID: 10537329
[TBL] [Abstract][Full Text] [Related]
6. Expression of girdin in human colorectal cancer and its association with tumor progression.
Jun BY; Kim SW; Jung CK; Cho YK; Lee IS; Choi MG; Choi KY; Oh ST
Dis Colon Rectum; 2013 Jan; 56(1):51-7. PubMed ID: 23222280
[TBL] [Abstract][Full Text] [Related]
7. The impact of Girdin expression on recurrence-free survival in patients with luminal-type breast cancer.
Nishimae K; Tsunoda N; Yokoyama Y; Kokuryo T; Iwakoshi A; Takahashi M; Nagino M
Breast Cancer; 2015 Sep; 22(5):445-51. PubMed ID: 24155038
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor receptor-assicated factor 4 correlates with expression of Girdin and promotes nuclear translocation of Girdin in breast cancer.
Wang A; Wang J; Sun L; Jin J; Ren H; Yang F; Diao K; Wei M; Mi X
Mol Med Rep; 2015 May; 11(5):3635-41. PubMed ID: 25591657
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
11. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer.
Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Sugano K; Ohkura H
J Med Assoc Thai; 1996 Nov; 79(11):715-21. PubMed ID: 8997010
[TBL] [Abstract][Full Text] [Related]
13. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
[TBL] [Abstract][Full Text] [Related]
14. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
[TBL] [Abstract][Full Text] [Related]
15. alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
Ivanov O; Chen F; Wiley EL; Keswani A; Diaz LK; Memmel HC; Rademaker A; Gradishar WJ; Morrow M; Khan SA; Cryns VL
Breast Cancer Res Treat; 2008 Oct; 111(3):411-7. PubMed ID: 17968656
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.
Mulligan AM; O'Malley FP; Ennis M; Fantus IG; Goodwin PJ
Breast Cancer Res Treat; 2007 Nov; 106(1):39-47. PubMed ID: 17221153
[TBL] [Abstract][Full Text] [Related]
17. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of p53 and c-erbB-2 oncoproteins overexpression in patients with breast cancer.
Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Chindavijak K
J Med Assoc Thai; 1998 Sep; 81(9):698-704. PubMed ID: 9737128
[TBL] [Abstract][Full Text] [Related]
19. Reassessing tumor markers in local recurrences of breast cancer: a new insight.
Pedrini JL; Pedrini M; Savaris RF; Machado L; Grudzinski M; Zettler CG
Med Sci Monit; 2004 Dec; 10(12):BR462-7. PubMed ID: 15567977
[TBL] [Abstract][Full Text] [Related]
20. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
Mihai R; Stevens J; McKinney C; Ibrahim NB
Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
